Annals of the Rheumatic Diseases | ARD is an international peer-reviewed journal covering all aspects of rheumatology, including musculoskeletal conditions, arthritic disease and connective tissue disorders.

Intro Widget

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.

ARD is an official journal of EULAR.

Free lay summaries are provided for selected research articles. You can keep up with the latest news via Twitter and Facebook.

Editor-in-Chief: Professor Josef Smolen, University of Vienna, Austria
Editorial team

Impact Factor: 12.350

Authors

Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.

The Author Information section provides general guidelines and requirements for specific article types.

Information is also provided on editorial policies and open access.

Impact Factor: 12.350

Author information

Submit a paper

Intro Widget

Latest Articles

Basic and translational research:

Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation

Correspondence response:

Response to ’Response to viewpoint ’Defining refractory rheumatoid arthritis’ by Buch’ by Roodenrijs et al

Clinical and epidemiological research:

Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis

Correspondence:

Digital heath in rheumatology

Letter:

Secretory form of rheumatoid arthritis–associated autoantibodies in serum are mainly of the IgM isotype, suggesting a continuous reactivation of autoantibody responses at mucosal surfaces

Altmetrics

Related Journals

Most Read Articles

Recommendation:

2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis

Recommendation:

2018 update of the EULAR recommendations for the management of Behçet’s syndrome

Clinical and epidemiological research:

Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis

Clinical and epidemiological research:

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study

Recommendation:

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)

Authors